Before you sign, get written answers to six questions: what evidence supports the product in your specialty, what a clinician must review and approve, what the product is intended to do, where the audio and transcripts go, what your data protection assessment needs from the vendor, and how you will measure the result. Ambient scribes are the furthest-along provider AI use case, but the evidence is narrower than most sales decks suggest.
What does the evidence actually show?
Ambient documentation is the furthest-along provider use case. Bain and KLAS reported in October 2025 that about one in five surveyed providers were at full ambient rollout and about two in five were piloting. The evidence supports clinician-reviewed draft notes and help with documentation time. The Nuffield Trust's February 2026 review did not find proof of downstream safety, extra capacity or cash-releasing savings.
Accuracy is the other half. A prospective pilot published in JMIR Medical Informatics in April 2026 had clinicians evaluate 356 notes from one tool. They found omissions in 18% and hallucinations in 11.5%, while 94.7% of notes were free of significant errors. One tool and one sample is not a benchmark for every product, but it shows why clinician review is the control that makes a scribe safe, not an optional extra.
Which questions belong in the vendor conversation?
Put these in writing, and treat vague answers as answers:
- Evidence: what results exist for my specialty and visit types, who measured them, and were they independent of the vendor?
- Intended use: what is the written intended-use statement, and does any feature suggest diagnoses, place orders or take clinical action?
- Review: can a note reach the chart without clinician approval, and are edits recorded so we can see what clinicians change?
- Data: is audio kept, for how long, where is it stored, who at the vendor can open it, and is any of it used to train models?
- Roles: who is the processor or business associate, which subcontractors touch the data, and how are incidents reported to us?
- Safety: what clinical safety documentation exists, such as a hazard log and safety case?
- Change control: how are we told about model or feature changes, and can we switch a new feature off?
- Exit: how do we export notes and delete audio and transcripts if we leave?
Is a scribe a medical device?
It depends on intended use, not the label. On 29 July 2026 the MHRA and NHS England clarified that tools producing transcription, summaries, draft correspondence or suggested codes for clinician review alone may fall outside medical-device regulation. Products intended for diagnosis, treatment or automated clinical action fall inside it. A product that starts as a note-taker and adds suggested diagnoses or orders can change category. The same intended-use question applies in the US under FDA's clinical decision support guidance, finalized on 6 January 2026 and reissued on 29 January 2026.
What do privacy and clinical safety rules expect?
In England, NHS guidance first issued on 27 April 2025, with implementation material updated through 29 July 2026, expects patient information and permission, a legal basis, a data protection impact assessment (DPIA) when required, supplier assurance, clinical safety work, clinician review and approval of outputs, security and monitoring. It does not say consent is always the GDPR basis, so establish the basis and whether permission is needed in context. A self-certified supplier registry launched in January 2026, but it is not NHS endorsement or a substitute for procurement checks. DCB0129 safety work sits with the supplier and DCB0160 with the deploying organization.
In the US, the OCR materials we cite do not set out a separate HIPAA rule for AI. The existing Privacy and Security Rules apply: map the data flow, run a Security Rule risk analysis and sign a business associate agreement with any vendor that handles PHI. A cloud service does not remove those duties. Recording rules vary by state, so confirm your notice and consent steps with qualified counsel.
What happens between the recording and the chart?
The review step is where safety is won or lost, so define it before go-live. The clinician reviews every note, fixes what is wrong or missing and approves it before filing. The medical director sets what a review must catch, such as omissions, wrong laterality, medication changes and statements the patient never made. The practice manager should be able to see edit rates and how long notes wait unsigned.
Watch scope creep. Letters, coding suggestions and connected workflows are emerging, not proven, and a scribe placing orders on its own is speculative. Treat each new function as a new pilot with its own review owner. AI governance work, such as an inventory of AI uses, a risk tier for each and a named owner, stops that from happening by accident.
How do you measure whether it worked?
Set the baseline before the pilot. An NHS evaluation warns that minutes saved do not automatically become extra appointments or cash savings, so decide in advance what you will count:
- Documentation time per visit and after-hours charting, per clinician.
- Note edit rate and the errors clinicians report: omissions, unsupported statements, misattributed details.
- Time from end of visit to signed note.
- Clinician experience, including those who opt out and why.
- What the freed time became: shorter days, extra slots or longer visits, whichever you intended.
Pilot with volunteer clinicians across a mix of visit types and agree stop conditions in writing, such as a pattern of significant errors or low sign-off rates. Medical clinics with several specialties should measure each separately. For hospitals and health systems, ask which service lines a vendor's results come from.
Next steps before you sign
- Get specialty-specific evidence and the vendor's own error and edit-rate data.
- Write the intended-use statement into the contract, with notice before any change in function.
- Put the clinician review and approval step into your clinical policy.
- Complete the DPIA (UK) or risk analysis and business associate agreement (US) before any audio is recorded.
Frequently asked questions
Does ambient documentation reduce clinician documentation time?
Evidence supports it as help with documentation time when clinicians review draft notes. The Nuffield Trust (February 2026) did not find proof of downstream safety, extra capacity or cash savings, so measure your own results.
Does the NHS supplier registry mean a scribe is approved?
No. The self-certified registry launched in January 2026 supports local assurance, but it is not NHS endorsement and does not replace your own procurement checks.
Can a scribe place orders or code visits on its own?
Not as a proven, routine feature. Letters and coding suggestions are emerging, and independent order placement is speculative. Keep a clinician approving anything that enters the chart.
Do patients have to consent to being recorded?
NHS guidance expects patient information and permission and a legal basis, without saying GDPR consent always applies. In the US, state recording laws vary, so build a notice and an opt-out into the visit workflow.